Efficacy and Safety of Alemtuzumab in Multiple Sclerosis and Impact on Nursing Role

Alemtuzumab, a humanized monoclonal antibody, has shown efficacy for relapsing-remitting multiple sclerosis (MS) in phase 2 and phase 3 trials. Compared with subcutaneous interferon beta-1a, alemtuzumab significantly reduced the risk for accumulation of disability and the rate of relapse, and improv...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Caon, Christina, Meyer, Cathy, Mayer, Lori, Smith, M. Shelton
Format: Artigo
Sprog:Inglês
Udgivet: The Consortium of Multiple Sclerosis Centers 2013
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3883016/
https://ncbi.nlm.nih.gov/pubmed/24453779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2013-004
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker